These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Use of beta-adrenergic receptor blocking drugs in psychiatry. Whitlock FA; Price J Drugs; 1974; 8(2):109-24. PubMed ID: 4154835 [No Abstract] [Full Text] [Related]
4. [Effect of Coretal Polfa (Oxprenolol) on parkinsonian tremor and benign essential tremor]. Dowzenko A; Buksowicz C; Kuran W Neurol Neurochir Pol; 1976; 10(1):49-53. PubMed ID: 768793 [TBL] [Abstract][Full Text] [Related]
5. Clinical trials of oxprenolol in anxiety. Elsdon-Dew RW Scott Med J; 1975 Nov; 20(6):286-7. PubMed ID: 4887 [No Abstract] [Full Text] [Related]
6. Oxprenolol in the treatment of examination nerves. Krishnan G Scott Med J; 1975 Nov; 20(6):288-9. PubMed ID: 4888 [No Abstract] [Full Text] [Related]
7. [Clinical pharmacology of a new beta-adrenergic blocking agent--Trasicor]. Votchal BE; Zamotaev IP; Lozinskiĭ LG; Sandomirskiĭ BL; Vorob'eva ZV Ter Arkh; 1973 Aug; 45(8):10-4. PubMed ID: 4149629 [No Abstract] [Full Text] [Related]
8. [Effective treatment of theophylline poisoning using a beta adrenergic blockader]. Katona Z Orv Hetil; 1990 Jul; 131(29):1591-2. PubMed ID: 1975436 [No Abstract] [Full Text] [Related]
9. Oxprenolol in Parkinson's disease. Jackson R; Crawford CO; Peel JS N Z Med J; 1971 Oct; 74(473):246-7. PubMed ID: 4399810 [No Abstract] [Full Text] [Related]
10. [Effectiveness of treatment with beta-blocking agents and diuretics in fixed combination, in aged hypertensive patients]. Paciaroni E; Quattrini L; Saccomanno G; Andreoni A G Ital Cardiol; 1980; 10(12):1737-41. PubMed ID: 6114010 [TBL] [Abstract][Full Text] [Related]
11. Clinical experience with beta-blockers in consultant psychiatric practice. Hawkings JR Scott Med J; 1975 Nov; 20(6):294-8. PubMed ID: 4893 [No Abstract] [Full Text] [Related]
12. [Effect of 3-month treatment with propranolol, oxprenolol, metoprolol and pindolol on plasma lipids and lipoproteins in patients with primary arterial hypertension]. Sznajderman M; Cybulska I; Niegowska J; Zawadzki Z; Sznajderman M Kardiol Pol; 1985; 28(7):489-99. PubMed ID: 2868145 [No Abstract] [Full Text] [Related]
20. Clinical pharmacological evaluation of beta-receptor antagonists. I. The effect of propranolol, oxprenolol, alprenolol on some central circulatory parameters in patients with essential circulatory hyperkinesis (ECH). Békés M; Matos L; Rausch J; Török E Int J Clin Pharmacol; 1972 Jun; 6(2):161-6. PubMed ID: 4404774 [No Abstract] [Full Text] [Related] [Next] [New Search]